Archives cancer

by in
Entry Author Date Location
Dendreon Gets $296M Bid From Valeant as Bankruptcy Auction Looms 01/30/15 Seattle
Aspyrian Therapeutics Raises $8.5M for New Tumor Immunotherapy 01/27/15 San Diego
Array Biopharma Gets Rights to Second Novartis Cancer Drug 01/23/15 Boulder/Denver
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
Surface Oncology Raises $35M to Develop Cancer Immunotherapies 01/08/15 Boston
With $21M, Retooled Blend Whips up Mini-Smart Bombs For Cancer 01/07/15 Boston
Tracon Files for $57.5M IPO to Move Cancer Drugs to Next Stage 01/06/15 San Diego
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
Oncothyreon Pays $20M for Array BioPharma’s Breast Cancer Drug 12/12/14 Boulder/Denver
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Array and Novartis End Development Deal for Cancer Drug Binimetinib 12/04/14 Boulder/Denver
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
Dallas Startups Pitch for Better Living at Health Wildcatters Day 11/24/14 Texas
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
Clovis Shares Drop Following Release of Cancer-Drug Trial Data 11/19/14 Boulder/Denver
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
Déjà Vu for Agios as Second Drug Shines in Small Blood Cancer Study 11/18/14 Boston
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
Celldex Touts Brain Cancer Vaccine Data, Talks FDA Strategy 11/14/14 New York
Device Maker Says Ebola Patient Recovered After Blood Filtration 11/14/14 San Diego
What Early Looks From ASH Tell Us About Cancer Immunotherapy 11/07/14 National
Texas Roundup: “Moon Shots,” TeVido, TMCx, Clarify & Spanning 11/04/14 Texas
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer 11/03/14 Texas
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
Invest Michigan Awards $275K to Four Early-Stage Tech Startups 10/28/14 Detroit
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
As Virus Spreads to U.S., Tekmira CEO Answers Ebola Questions 10/07/14 Seattle
Page 3 of 59 « previous page · next page »